TNN and neoplasm: To circumvent these problems, instead of targeting the integrins, which are in principle present on both normal and malignant cells, another strategy aims at tumor-promoting integrin ligands, such as ED-B fibronectin, tenascin-C, and tenascin W [252, 253, 255].